Page last updated: 2024-11-05

ethambutol hydrochloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethambutol hydrochloride is an antimycobacterial drug used to treat tuberculosis (TB). It is a synthetic compound that was first synthesized in the 1960s. Ethambutol hydrochloride works by inhibiting the synthesis of mycolic acids, which are essential components of the cell wall of Mycobacterium tuberculosis. The drug is typically administered orally and has a relatively long half-life. Ethambutol hydrochloride is generally well-tolerated, but side effects can include visual disturbances, optic neuritis, and gastrointestinal upset. It is important to note that ethambutol hydrochloride should not be used in patients with optic nerve damage. Ethambutol hydrochloride is a valuable tool in the treatment of TB, especially in cases of multidrug-resistant TB. It is often used in combination with other antimycobacterial agents to increase effectiveness and reduce the risk of drug resistance. Research into ethambutol hydrochloride continues to explore its potential benefits and limitations, including its effectiveness against different strains of Mycobacterium tuberculosis, its potential interactions with other medications, and its long-term effects on the body.'

ethambutol dihydrochloride : The dihydrchloride salt of ethambutol. A bacteriostatic antimycobacterial drug, it is effective against Mycobacterium tuberculosis and some other mycobacteria. It is used in combination with other antituberculous drugs in the treatment of pulmonary and extrapulmonary tuberculosis; resistant strains of M. tuberculosis are readily produced if ethambutol dihydrochloride is used alone. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID14051
CHEMBL ID3140361
CHEBI ID4878
SCHEMBL ID650049
MeSH IDM0007816

Synonyms (110)

Synonym
nsc 757022
unii-qe4vw5fo07
qe4vw5fo07 ,
ethambutol hydrochloride [usan:usp:jan]
ethambutol 2hcl
(s-(r*,r*))-2,2'-(ethylenediimino)dibutan-1-ol dihydrochloride
(+-)-2,2'-(ethylenediimino)-di-1-butanol dihydrochloride
1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, dihydrochloride, (r*,r*)-
(+)-2,2'-(ethylenediimino)-di-1-butanol dihydrochloride
einecs 213-970-7
ethambutol hydrochloride
(+-)-ethambutol dihydrochloride
ethambutol hcl
1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, dihydrochloride, (s-(r*,r*))-
1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, dihydrochloride, (r-(r*,r*))-
cl 40881
1-butanol, (1,2-ethanediyldiimino)bis-, dihydrochloride, (r*,r*)-(+-)-
ccris 6606
1-butanol, 2,2'-(ethylenediimino)di-, dihydrochloride, (+-)-
dadibutol
myambutol
1-butanol, 2,2'-(ethylenediimino)di-, dihydrochloride, (+)-
1070-11-7
ethambutol dihydrochloride
cas-1070-11-7
NCGC00016560-01
tibutol
EMB ,
ethambutol dihydrochloride, antimycobacterial
D00878
ethambutol hydrochloride (jp17/usp)
myambutol (tn)
SPECTRUM1500288
hydrochloride, ethambutol
dexambutol
etibi
ebutol
CHEBI:4878 ,
cl-40881
HMS1920M18
KUC109574C
ksc-27-052b
nsc-757022
dtxsid4045345 ,
dtxcid2025345
tox21_110494
S4004
CCG-40232
jng307dj5x ,
ethambutol dihydrochloride, dl-
unii-jng307dj5x
22196-75-4
1-butanol, 2,2'(1,2-ethanediyldiimino)bis-, dihydrochloride, (-(r*,r*))
ethambutol dihydrochloride [mi]
29326-86-1
ethambutol hydrochloride [usan]
ethambutol hydrochloride [usp monograph]
tambutol
ethambutol hydrochloride [ep impurity]
ethambutol dihydrochloride [who-dd]
ethambutoli hydrochloridum [who-ip latin]
ethambutol hydrochloride [vandf]
ethambutol hydrochloride [mart.]
ethambutol hydrochloride [orange book]
servambutol
ethambutol hydrochloride [jan]
ethambutol hydrochloride [ep monograph]
ethambutol hydrochloride [who-ip]
1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, hydrochloride (1:2), (2s,2's)-
ethambutol hydrochloride [usp-rs]
1-butanol, 2,2'-(1,2-ethanediyldiimino)bis-, dihydrochloride, (2r,2'r)-rel-
mycobutol
etapiam
(2s)-2-[(2-{[(2s)-1-hydroxybutan-2-yl]amino}ethyl)amino]butan-1-ol dihydrochloride
HY-B0535A
ethambutol (dihydrochloride) ,
SCHEMBL650049
NCGC00178864-03
tox21_110494_1
AKOS024258527
(2s)-2-[2-[[(1s)-1-(hydroxymethyl)propyl]amino]ethylamino]butan-1-ol dihydrochloride
(2s,2's)-2,2'-(ethane-1,2-diylbis(azanediyl))bis(butan-1-ol) dihydrochloride
CHEMBL3140361
ethambutoli hydrochloridum
(s,s)-2,2'-(1,2-ethanediyldiimino)bis-1-butanol dihydrochloride
E1011
(s,s)-n,n'-bis(1-hydroxy-2-butyl)ethylenediamine dihydrochloride
2,2'-(1,2-ethanediyldiimino)bis-1-butanol dihydrochloride
mfcd21364080
cl40881
emb dihydrochloride
ethambutol hydrochloride, united states pharmacopeia (usp) reference standard
ethambutol hydrochloride, european pharmacopoeia (ep) reference standard
ethambutol for system suitability, european pharmacopoeia (ep) reference standard
2,2'-[ethane-1,2-diyldi(imino)]dibutan-1-ol dihydrochloride
ethambutol hydrochloride, pharmaceutical secondary standard; certified reference material
SW219109-1
Q27106530
AUAHHJJRFHRVPV-BZDVOYDHSA-N
A895715
(2s)-2-[2-[[(2s)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol;dihydrochloride
EN300-123643
Z1486001934
ethambutol hydrochloride (ep impurity)
ethambutol hydrochloride (usan:usp:jan)
ethambutol hydrochloride (ep monograph)
(2s,2's)- 2,2'-(ethylenediimino)bis(butan-1-ol) dihydrochloride
ethambutol hydrochloride (usp monograph)
ethambutol hydrochloride (mart.)
ethambutol hydrochloride (usp-rs)

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antitubercular agentA substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydrochlorideA salt formally resulting from the reaction of hydrochloric acid with an organic base.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency5.74130.000214.376460.0339AID720691
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-binding cassette sub-family C member 3Homo sapiens (human)IC50 (µMol)88.20000.63154.45319.3000AID1473740
Multidrug resistance-associated protein 4Homo sapiens (human)IC50 (µMol)133.00000.20005.677410.0000AID1473741
Bile salt export pumpHomo sapiens (human)IC50 (µMol)133.00000.11007.190310.0000AID1473738
Canalicular multispecific organic anion transporter 1Homo sapiens (human)IC50 (µMol)133.00002.41006.343310.0000AID1473739
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (41)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
bile acid and bile salt transportATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transportATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
leukotriene transportATP-binding cassette sub-family C member 3Homo sapiens (human)
monoatomic anion transmembrane transportATP-binding cassette sub-family C member 3Homo sapiens (human)
transport across blood-brain barrierATP-binding cassette sub-family C member 3Homo sapiens (human)
prostaglandin secretionMultidrug resistance-associated protein 4Homo sapiens (human)
cilium assemblyMultidrug resistance-associated protein 4Homo sapiens (human)
platelet degranulationMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
bile acid and bile salt transportMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transportMultidrug resistance-associated protein 4Homo sapiens (human)
urate transportMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
cAMP transportMultidrug resistance-associated protein 4Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 4Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 4Homo sapiens (human)
guanine nucleotide transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
negative regulation of gene expressionCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bile acid and bile salt transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
heme catabolic processCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic export from cellCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transepithelial transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
leukotriene transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
monoatomic anion transmembrane transportCanalicular multispecific organic anion transporter 1Homo sapiens (human)
transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transport across blood-brain barrierCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (24)

Processvia Protein(s)Taxonomy
ATP bindingATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
glucuronoside transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type bile acid transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATP hydrolysis activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
icosanoid transmembrane transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
ABC-type transporter activityATP-binding cassette sub-family C member 3Homo sapiens (human)
guanine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ATP bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
urate transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
purine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type bile acid transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
15-hydroxyprostaglandin dehydrogenase (NAD+) activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
protein bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP bindingCanalicular multispecific organic anion transporter 1Homo sapiens (human)
organic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type xenobiotic transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
bilirubin transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATP hydrolysis activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
xenobiotic transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
ABC-type transporter activityCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basal plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
basolateral plasma membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
membraneATP-binding cassette sub-family C member 3Homo sapiens (human)
nucleolusMultidrug resistance-associated protein 4Homo sapiens (human)
Golgi apparatusMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
platelet dense granule membraneMultidrug resistance-associated protein 4Homo sapiens (human)
external side of apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
cell surfaceCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
intercellular canaliculusCanalicular multispecific organic anion transporter 1Homo sapiens (human)
apical plasma membraneCanalicular multispecific organic anion transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1453421Antimicrobial activity against Mycobacterium tuberculosis H37Rv after 7 days by resazurin microtiter assay2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Synthesis, antimycobacterial activity and docking study of 2-aroyl-[1]benzopyrano[4,3-c]pyrazol-4(1H)-one derivatives and related hydrazide-hydrazones.
AID1061814Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 45 days2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Synthesis and antimycobacterial activity of novel camphane-based agents.
AID1473738Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1473741Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID1756899Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 45 days by Lowenstein-Jensen method2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
AID1055553Antimycobacterial activity against rifampin/isoniazid-resistant Mycobacterium tuberculosis 43 assessed as growth inhibition after 45 days by Canetti proportional method2013European journal of medicinal chemistry, , Volume: 70Novel camphane-based anti-tuberculosis agents with nanomolar activity.
AID744653Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 45 days by Lowenstein-Jensen method2013European journal of medicinal chemistry, May, Volume: 63Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity.
AID637875Solubility of the compound in deionized water2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID1143496Cytotoxicity against HEK293T cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Jun-23, Volume: 81Antimycobacterial activity of chiral aminoalcohols with camphane scaffold.
AID744652Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 43 assessed as growth inhibition after 45 days by Lowenstein-Jensen method2013European journal of medicinal chemistry, May, Volume: 63Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity.
AID637874Selectivity index, ratio of IC50 for human HEK293T cells to MIC for Mycobacterium tuberculosis H37Rv2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID1331302Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 45 days2017Bioorganic & medicinal chemistry letters, 01-15, Volume: 27, Issue:2
Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2H-chromene and coumarin scaffold.
AID1473739Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID744647Antimycobacterial activity against Mycobacterium tuberculosis assessed as growth inhibition2013European journal of medicinal chemistry, May, Volume: 63Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity.
AID637872Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 45 days2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID744648Selectivity index, ratio of IC50 for HEK293T cells to MIC for Mycobacterium tuberculosis H37Rv2013European journal of medicinal chemistry, May, Volume: 63Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity.
AID1055552Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 45 days by Canetti proportional method2013European journal of medicinal chemistry, , Volume: 70Novel camphane-based anti-tuberculosis agents with nanomolar activity.
AID1473740Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay2013Toxicological sciences : an official journal of the Society of Toxicology, Nov, Volume: 136, Issue:1
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
AID744649Cytotoxicity against HEK293T cells assessed as cell viability after 72 hrs by MTT assay2013European journal of medicinal chemistry, May, Volume: 63Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity.
AID637873Cytotoxicity against human HEK293T cells after 72 hrs by MTT assay2012European journal of medicinal chemistry, Feb, Volume: 48Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
AID1143495Antimycobacterial activity against rifampicin and isoniazid-resistant Mycobacterium tuberculosis 43 assessed as growth inhibition2014European journal of medicinal chemistry, Jun-23, Volume: 81Antimycobacterial activity of chiral aminoalcohols with camphane scaffold.
AID1143494Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition after 45 days2014European journal of medicinal chemistry, Jun-23, Volume: 81Antimycobacterial activity of chiral aminoalcohols with camphane scaffold.
AID1158126Antituberculosis activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth after 45 days2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Theophylline-7-acetic acid derivatives with amino acids as anti-tuberculosis agents.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (80.00)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.90 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.85 (4.65)
Search Engine Demand Index97.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (62.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]